NCT06929455 Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines
| NCT ID | NCT06929455 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Monell Chemical Senses Center |
| Condition | Healthy Adults |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-03-18 |
| Primary Completion | 2026-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-03-18 with a primary completion date of 2026-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Many people, particularly small children, must take drugs in liquid form because they cannot swallow pills or capsules. The bad taste of some liquid drugs can keep patients from taking drugs they need for their health. Our main goal in this research study is find ingredients that might make drugs taste better. Participants in this research study will be healthy adults between the ages of 18 and 60 years old. Participants will taste samples (liquids or gels) containing active pharmaceutical ingredients (substances in medications that produce desired health effects). After tasting each sample participants will spit out the sample and rinse with water (no samples will be swallowed). Active pharmaceutical ingredients of current interest are: 1) tenofovir alafenamide, used to treat HIV infection and hepatitis B, 2) rifampicin, used to treat tuberculosis, 3) rifapentine, used to treat tuberculosis, and 4) levofloxacin, used to treat various bacterial infections). Other active pharmaceutical ingredients may be added as the study goes forward. Participants will be instructed to taste samples both with and without experimental flavor ingredients added and judge how the samples taste. People who volunteer for the study will be instructed to complete many repeated visits to the Monell Center (University City area of Philadelphia) for tasting sessions. Tasting visits will last between 1 and 2 hours.
Eligibility Criteria
Inclusion Criteria: * Between the ages of 18 and 60; * Generally healthy by self-report; * All races/ethnicities, both men and women; * Able to provide informed consent; * Able to attend repeated visits to Monell for sensory testing; * Willing to follow instructions (e.g., refrain from eating or drinking for at least 1 hour before sessions, willing to remain on site for one hour after tasting an API that the participant has never tasted before). - Exclusion Criteria: * Under 18 or over 60; * Pregnant, nursing, or plans to become pregnant; * Unable to provide consent (including limited ability to understand written and spoken English); * Tobacco, vape, marijuana, or tetrahydrocannabinol cartridge users. We will accept people who have used tobacco or marijuana products on occasion, but not regular users; * Known drug or food allergies of any kind; * Diabetes or other metabolic disorder; * Liver issues of any kind, including viral hepatitis; * Kidney issues of any kind; * Other chronic illness, including cardiovascular, neurological, immune disorders, or any other serious acute or chronic condition * Dentures or other major dental implants; * Condition affecting the oral cavity, including dry mouth, burning mouth syndrome, active sores or blisters, geographic tongue, or other disorders * Current infection or cold, flu, or infection with SARS-CoV-2 within the last four weeks; * Unable to taste or smell * Daily use, or use within the last four weeks, of either prescription or over-the-counter medications (except for birth control) * History of tuberculosis (including latent tuberculosis), positive skin or other tuberculosis test at any time in the past, birth in or residence in a country with high tuberculosis rates, known contact with someone who is tuberculosis positive * HIV infection
Contact & Investigator
Paul M Wise, Ph.D.
PRINCIPAL INVESTIGATOR
Monell Chemical Senses Center
Frequently Asked Questions
Who can join the NCT06929455 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Healthy Adults. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06929455 currently recruiting?
Yes, NCT06929455 is actively recruiting participants. Contact the research team at TasteOfMedicinesStudy@monell.org for enrollment information.
Where is the NCT06929455 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT06929455 clinical trial?
NCT06929455 is sponsored by Monell Chemical Senses Center. The principal investigator is Paul M Wise, Ph.D. at Monell Chemical Senses Center. The trial plans to enroll 100 participants.